Publications by authors named "G Sugahara"

Article Synopsis
  • The study looked at a protein called TSPO that helps move cholesterol in mitochondria, and Atriol is a substance that can stop TSPO from binding to cholesterol.
  • Researchers found that Atriol can help improve a liver disease called MASH by fixing mitochondrial function and reducing inflammation.
  • In tests on rats with MASH, Atriol helped reduce fat buildup, inflammation, and other harmful effects, showing it might be a helpful treatment for this liver condition.
View Article and Find Full Text PDF

The ability to maintain functional hepatocytes has important implications for bioartificial liver development, cell-based therapies, drug screening, and tissue engineering. Several approaches can be used to restore hepatocyte function in vitro, including coating a culture substrate with extracellular matrix (ECM), encapsulating cells within biomimetic gels (Collagen- or Matrigel-based), or co-cultivation with other cells. This paper describes the use of bioactive heparin-based core-shell microcapsules to form and cultivate hepatocyte spheroids.

View Article and Find Full Text PDF

Hepatitis delta virus (HDV), a satellite virus of HBV, is regarded as the most severe type of hepatitis virus because of the substantial morbidity and mortality. The IFN system is the first line of defense against viral infections and an essential element of antiviral immunity; however, the role of the hepatic IFN system in controlling HBV-HDV infection remains poorly understood. Herein, we showed that HDV infection of human hepatocytes induced a potent and persistent activation of the IFN system whereas HBV was inert in triggering hepatic antiviral response.

View Article and Find Full Text PDF

Human hepatocyte culture system represents by far the most physiologically relevant model for our understanding of liver biology and diseases; however, its versatility has been limited due to the rapid and progressive loss of genuine characteristics, indicating the inadequacy of in vitro milieu for fate maintenance. This study, therefore, is designed to define environmental requirements necessary to sustain the homeostasis of terminally differentiated hepatocytes. Our study reveals that the supplementation of dimethyl sulfoxide (DMSO) is indispensable in mitigating fate deterioration and promoting adaptation to the in vitro environment, resulting in the restoration of tight cell-cell contact, cellular architecture, and polarity.

View Article and Find Full Text PDF
Article Synopsis
  • Nonalcoholic fatty liver disease (NAFLD) and its more severe form, steatohepatitis (NASH), are prevalent liver disorders in developed nations but have no approved drugs for treatment yet.
  • The study introduces a new model using human liver chimeric mice that mimics human NASH, overcoming challenges related to animal testing due to species differences.
  • The research successfully demonstrated that treating these chimeric mice with a drug called Elafibranor significantly improved liver damage, indicating this model could help discover new therapies and understand NASH better.
View Article and Find Full Text PDF